Improving vaccination rates in high-risk groups

Video

A look at a recently presented study on improving 23-valent pneumococcal polysaccharide vaccine uptake in groups that are at high risk.

Anthony W. Gannon, MD, a pediatric endocrinilogist at Nemours Children's in Wilmington, Delaware, sat down with Contemporary Pediatrics to discuss a poster presented at the 2022 Pediatric Academic Societies meeting that examined the impact of a quality improvement program on improving 23-valent pneumococcal polysaccharide vaccine uptake in 3 groups that are at high risk. He shared the ins and outs of the research, how other health systems could consider a similar project, and what the next steps are.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
C. Buddy Creech, MD, discusses the future directions in vaccinology
Jonathan Miller, MD, on how pediatric influenza deaths highlight importance of vaccination, early recognition
 Diane Straub, MD, addresses STI screening and confidential care in adolescents
© 2025 MJH Life Sciences

All rights reserved.